EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:

6 Months Ended

Sep. 30, 2019

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS' EQUITY:

EARNINGS (LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:

LOSS) PER SHARE AND STOCKHOLDERS’ EQUITY:

Earnings (Loss) Per Share

A reconciliation of the numerator and denominator of basic and diluted loss per share is shown below (in thousands, except per share amounts): 

	For the three months ended				For the six months ended
	September 30,				September 30,
	2019		2018		2019		2018
Basic earnings (loss) per share:
Net loss from continuing operations	$	(40,202)	$	(41,180)	$	(82,342)	$	(68,998)
Earnings from discontinued operations, net of tax	—		61,803		—		86,606
Net earnings (loss)	$	(40,202)	$	20,623	$	(82,342)	$	17,608
Basic weighted-average shares outstanding	67,684		77,448		68,295		77,192
Continuing operations	$	(0.59)	$	(0.53)	$	(1.21)	$	(0.89)
Discontinued operations	—		0.80		—		1.12
Basic earnings (loss) per share	$	(0.59)	$	0.27	$	(1.21)	$	0.23
Diluted earnings (loss) per share:
Basic weighted-average shares outstanding	67,684		77,448		68,295		77,192
Dilutive effect of common stock options, warrants, and restricted stock as computed under the treasury stock method	—		—		—		—
Diluted weighted-average shares outstanding	67,684		77,448		68,295		77,192
Continuing operations	$	(0.59)	$	(0.53)	$	(1.21)	$	(0.89)
Discontinued operations	—		0.80		—		1.12
Diluted earnings (loss) per share	$	(0.59)	$	0.27	$	(1.21)	$	0.23

Due to the net loss from continuing operations during the three and six months ended September 30, 2019 and 2018, the dilutive effect of options and restricted stock units was excluded from the diluted loss per share calculation since the impact on the calculation was anti-dilutive. These anti-dilutive units are shown below (shares in thousands):

	For the three months ended		For the six months ended
	September 30,		September 30,
	2019	2018	2019	2018
Number of shares outstanding under options, warrants and restricted stock units plans	2,391	4,773	2,586	3,554

Restricted stock units and warrants that were outstanding during the periods presented but were not included in the computation of diluted loss per share because the effect was anti-dilutive are shown below (shares in thousands): 

	For the three months ended		For the six months ended
	September 30,		September 30,
	2019	2018	2019	2018
Number of shares outstanding under warrants and restricted stock units plans	945	29	669	69

Stockholders’ Equity

Under the modified common stock repurchase program, the Company may purchase up to $1.0 billion of its common stock through the period ending December 31, 2020. During the six months ended September 30, 2019, the Company repurchased 2.1 million shares of its common stock for $100.5 million under the stock repurchase program.  Through September 30, 2019, the Company had repurchased a total of 24.7 million shares of its stock for $549.5 million under the stock repurchase program, leaving remaining capacity of $450.5 million.

Accumulated other comprehensive income balances of $6.6 million and $7.8 million at September 30, 2019 and March 31, 2019, respectively, reflect accumulated foreign currency translation adjustments.